127 related articles for article (PubMed ID: 2685821)
1. The activated eosinophil in allergy and asthma.
Kay AB; Frew AJ; Moqbel R; Walsh GM; Kurihara K; Cromwell O; Champion A; Hartnell A; Wardlaw AJ
Prog Clin Biol Res; 1989; 297():183-96; discussion 196-7. PubMed ID: 2685821
[TBL] [Abstract][Full Text] [Related]
2. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
3. Early activation or "priming" of eosinophils in asthma.
Bruijnzeel PL; Rihs S; Virchow JC; Warringa RA; Moser R; Walker C
Schweiz Med Wochenschr; 1992 Feb; 122(9):298-301. PubMed ID: 1546279
[TBL] [Abstract][Full Text] [Related]
4. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
Hartnell A; Robinson DS; Kay AB; Wardlaw AJ
Immunology; 1993 Oct; 80(2):281-6. PubMed ID: 8262555
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
6. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
7. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
8. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
Ebisawa M; Liu MC; Yamada T; Kato M; Lichtenstein LM; Bochner BS; Schleimer RP
J Immunol; 1994 May; 152(9):4590-6. PubMed ID: 8157972
[TBL] [Abstract][Full Text] [Related]
10. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells.
Lamas AM; Mulroney CM; Schleimer RP
J Immunol; 1988 Mar; 140(5):1500-5. PubMed ID: 3279115
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostate cancer cell growth by activated eosinophils.
Furbert-Harris P; Parish-Gause D; Laniyan I; Hunter KA; Okomo-Awich J; Vaughn TR; Forrest KC; Howland C; Abdelnaby A; Oredipe OA
Prostate; 2003 Oct; 57(2):165-75. PubMed ID: 12949941
[TBL] [Abstract][Full Text] [Related]
12. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
[TBL] [Abstract][Full Text] [Related]
13. Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators.
Plötz SG; Traidl-Hoffmann C; Feussner I; Kasche A; Feser A; Ring J; Jakob T; Behrendt H
J Allergy Clin Immunol; 2004 Jun; 113(6):1152-60. PubMed ID: 15208598
[TBL] [Abstract][Full Text] [Related]
14. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K
J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248
[TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
[TBL] [Abstract][Full Text] [Related]
16. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of airway eosinophils.
Busse WW; Nagata M; Sedgwick JB
Eur Respir J Suppl; 1996 Aug; 22():132s-135s. PubMed ID: 8871058
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 activates human peripheral blood eosinophils.
Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis.
Saito H; Morikawa H; Howie K; Crawford L; Baatjes AJ; Denburg E; Cyr MM; Denburg JA
Immunology; 2004 Oct; 113(2):246-52. PubMed ID: 15379985
[TBL] [Abstract][Full Text] [Related]
20. T cells and eosinophils in asthma.
Haczku A
Acta Microbiol Immunol Hung; 1998; 45(1):19-29. PubMed ID: 9595149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
